In the latest session, Compass Therapeutics Inc (NASDAQ: CMPX) closed at $2.12 down -0.93% from its previous closing price of $2.14. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 741718 shares were traded. CMPX stock price reached its highest trading level at $2.1600 during the session, while it also had its lowest trading level at $1.9600.
Ratios:
For a deeper understanding of Compass Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.26 and its Current Ratio is at 18.26. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on January 31, 2023, initiated with a Buy rating and assigned the stock a target price of $8.
On January 27, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 270.27M and an Enterprise Value of 108.61M.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $3.62, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is 1.7013, while the 200-Day Moving Average is calculated to be 2.0898.
Shares Statistics:
For the past three months, CMPX has traded an average of 537.53K shares per day and 456.03k over the past ten days. A total of 126.30M shares are outstanding, with a floating share count of 76.11M. Insiders hold about 40.30% of the company’s shares, while institutions hold 44.13% stake in the company. Shares short for CMPX as of Feb 29, 2024 were 1.84M with a Short Ratio of 3.43, compared to 2.18M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.44% and a Short% of Float of 2.02%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.11, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.07 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.31 and -$0.4 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.43, with 7 analysts recommending between -$0.31 and -$0.53.
